Title: Clinical observation on therapeutic effect of Low-molecule heparin calcium integrated with Yinxingdamo injection on progressive cerebral infarction
Abstract: Objective To observe the therapeutic effect of low-molecule heparin calcium integrated with Yinxingdamo injection on progressive cerebral infarction. Methods 96 patients with progressive cerebral infarction were randomly divided into two groups. 48 patients in control group, on the basis of routine treatment, were treated by Yinxingdamo injection 20 ml once a day,with a treatment course of 14 days. The other 48 patients in treatment group, on the basis of control group, were treated by low-molecule heparin calcium 0.5 mL once,twice a day, with a treatment course of 10 days. The scoring of nervous function defect before treatment and on the 3rd,7th,14th,28th day after treatment were conducted, and the therapeutic effects were evaluated in both groups. Results The scorings of nervous function defect in treatment group on the 7 th, 14 th, 28 th day after treatment were significantly decreased, compared with those before treatment (P0.01),so did with those of control group (P0.01). There was a significant difference in scoring of nervous function defect in control group on the 14th, 28th day before treatment and after treatment (P0.01). The therapeutic effect of treatment group was superior to that of control group, there were significant differences in effective rate and total effective rate between treatment group and control group(P0.05). Conclusion The low-molecule heparin calcium integrated with Yinxingdamo injection is effective in treating progressive cerebral infarction, which can delay the progression of state of illness effectively, improve nervous function defect and enhance therapeutic effect.
Publication Year: 2008
Publication Date: 2008-01-01
Language: en
Type: article
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot